FREE REPORT: Vector-Based Gene Therapy and Gene-Editing Products On-Going Clinical Trials

€0.00 Excl. VAT

Add to Wishlist

CONTENTS

 

  • 211 Ongoing Trials in More than 10 Therapeutic Areas

 

  • 106 Sponsors from 13 Countries Have Initiated These 211 Ongoing Trials

 

  • 68 % of On Going Trials with At Least One Location in the USA

 

  • 72 % of On Going Trials with At Least One Location in Europe

 

  • AAV-Based Vectors and Lentiviral Vectors are The Most Widely Used Vectors

 

  • 72 % of Ongoing Trials are Early-Phase Trials (I or I-II)

 

  • Hematological Diseases and Ophthalmological Diseases Are The Most Advanced Therapeutic Areas.

 

Mapping_GeneTherapyTrials_24112020

Related products

Products

Five Unicorns in the race for a mRNA-based vaccine against Sars-Cov2

€390.00 Excl. VAT

Add to cart
[section class="login-section" visibility="hide-for-small" padding="80px"]
[/section] [section label="one" class="login-signup-section" bg="363" bg_size="original" bg_pos="50% 0%" visibility="hide-for-small"]
[/section] [section class="login-section" visibility="show-for-small"]
[/section] [section label="one" bg_color="#194295" visibility="show-for-small"]
[/section]